
AMRN vs ARCT
$AMRN vs $ARCT head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
AMRN vs ARCT: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Only ARCT beat the market over the past year, by 18%, while AMRN trailed the S&P 500 at +8.8% by 42.6%.
- ·The last month has flipped the order: AMRN has held up better over the month (-2.3% against -30.8%) even though ARCT leads over the year.
- ·ARCT has support 14.2% below at $6.51; AMRN has no tested support within 35% under its price.
- ·AMRN is within 0.7% of resistance at $11.30, a price where it has stalled before.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
AMRN vs ARCT: the quick read
- ·AMRN is the larger company by market cap ($237M vs $232M).
- ·ARCT has been more active on our scanner (125 vs 36 alerts in 30 days).
- ·ARCT has the smaller float (23.2M vs 41.3M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·ARCT draws far more of our scanner's attention, 125 unusual-volume alerts in 30 days against 36, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 2% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·They are pulling apart today: AMRN is outperforming the other by roughly 5.3 percentage points on the session.
Objective differences only. Not investment advice.
Watching AMRN or ARCT? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing AMRN and ARCT on TheDesperateTrader.
- Is AMRN or ARCT the better stock?
- "Better" depends on your goal, and these two are not alike. AMRN is the larger company by market cap ($237M vs $232M). ARCT has been more active on our scanner (125 vs 36 alerts in 30 days). ARCT has the smaller float (23.2M vs 41.3M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between AMRN and ARCT?
- The differences that matter: they are not in the same business - AMRN is pharmaceutical preparations and ARCT is pharmaceutical preparations; they are similar in size ($237M vs $232M); they trade at very different share prices ($11.21 vs $7.58); AMRN sits at 1% of its 52-week range against 17% for ARCT; our scanner flagged AMRN 36 times in the last 30 days against 125 for ARCT. Everything above is measured from the latest completed session and SEC filings.
- Which of AMRN and ARCT is more active right now?
- Right now AMRN is at about 1.2x its normal volume and ARCT is at about 0.9x, so AMRN is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is AMRN or ARCT in the stronger trend?
- AMRN is below its 50-day average of $12.31 and below its 200-day average of $14.06; ARCT is below its 50-day average of $11.87 and below its 200-day average of $9.12. They split the head-to-head evenly, 2 measures each (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading AMRN or ARCT? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore AMRN and ARCT comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.